
Ovid Therapeutics Inc. 2025 This autumn – Results – Earnings Call Presentation (NASDAQ:OVID) 2026-03-19
Q4: 2026-03-18 Earnings Summary EPS of $0.06 beats by $0.16 | Revenue of $718.00K (844.74% Y/Y) beats by $655.40K This article…

Q4: 2026-03-18 Earnings Summary EPS of $0.06 beats by $0.16 | Revenue of $718.00K (844.74% Y/Y) beats by $655.40K This article…

Trusted Editorial content, reviewed by leading industry experts and seasoned editors. Ad Disclosure Crypto prediction platform Polymarket and derivatives exchange…

EUROPEAN SESSION In the European session, we get three central bank policy decisions. The SNB is expected to hold interest…

For decades, the standard formula for financial success was the same: go to college, get a degree, and land a…

The pace of inflation rise is expected to see upward pressure from higher oil prices Global markets are volatile with…

Justine Iverson Hello, everyone, and welcome to today’s webinar. My name is Justine Iverson, and I look after the Corporate…

The FT reports on the matter, noting that US president Trump has given his word that the US would insure…

This article was written by Follow Over fifteen years of experience making contrarian bets based on my macro view and…

Trusted Editorial content, reviewed by leading industry experts and seasoned editors. Ad Disclosure Multiple bills meant to stop federal officials…

Summary: Bank of England expected to hold Bank Rate at 3.75% Middle East conflict-driven energy shock complicates outlook Inflation risks…
Get the latest tech, social media, politics, business, sports and many more news directly to your inbox.